ASH 2024: Polycythemia Vera and Myelofibrosis: Current and Future Standards of Care - Episode 17

MPN Milestones of 2024 and What’s Next for 2025

February 28, 2025

Andrew Kuykendall, MD, Naseema Gangat, MBBS , Claire Harrison, MD, FRCP, FRCPath , Raajit K. Rampal, MD, PhD, Pankit Vachhani, MD

Panelists discuss key accomplishments in the myeloproliferative neoplasm (MPN) space, highlighting pivotal developments that have shaped clinical practice, and share their excitement for 2025, including areas primed for significant progress and goals for the coming year.

Video Player is loading.

Current Time 0:00

Duration 0:00

Loaded: 0%

Stream Type LIVE

Remaining Time 0:00

EP. 1: Initial Treatment Strategies for Polycythemia Vera

EP. 2: Cytoreductive Therapy in PV Treatment Paradigm

EP. 3: JAK Inhibition in Polycythemia Vera: Treatment Updates

EP. 4: Interferon Therapy in PV

EP. 5: Safety Considerations for PV Therapy

EP. 6: Evolving Treatment Strategies in Polycythemia Vera: Insights Ffrom Trials and Real-World Evidence

EP. 7: Interferon Real- World Treatment Patterns in PV

EP. 8: Considerations for Polycythemia Vera Management: Patient Monitoring, Outcomes, and Risks

EP. 9: Future Considerations for Polycythemia Vera Management: Takeaways from ASH 2024

EP. 10: An Overview to Myelofibrosis and Disease Risk

EP. 11: Treatment Goals for Myelofibrosis

EP. 12: Personalizing Therapy in Myelofibrosis: Insights from Key Clinical Trials

EP. 13: Advancing Myelofibrosis Treatment: Personalized Strategies with Fedratinib and Ruxolitinib

EP. 14: Real-World Data in Myelofibrosis: Bridging the Gap Between Clinical Trials and Practice

EP. 15: Navigating Therapy Challenges in Myelofibrosis: Anemia Management and Disease-Specific Approaches

EP. 16: Myelofibrosis at ASH 2024: Key Updates and Emerging Therapies

Now Viewing

EP. 17: MPN Milestones of 2024 and What’s Next for 2025

Video content above is prompted by the following:

What accomplishments in the MPN space are you most proud of? Which developments stand out as pivotal in shaping clinical practice?
What are you most excited about in 2025? What areas are primed for significant progress? What do you hope to achieve in the coming year?